News & Updates
November 18, 2019
Nanjing, China Nov. 12, 2019 Nanjing CR Medicon Pharmaceutical Technology CO., Ltd., a Gold level member of Oracle […]
April 13, 2021
China-based pharmaceutical companies have experienced noteworthy success in achieving patient recruitment milestones, even in the […]
April 2, 2021
The ongoing pandemic has changed the landscape of clinical development in prominent ways. Conducting clinical […]
April 6, 2020
Time: Tue, 07 April 2020 11:00 AM – 12:30 PM (EST) As COVID-19 has become […]
December 26, 2019
NMPA released an annual report on ADR & ADE monitoring in China (the 2018 version). […]
December 25, 2019
In this publication, we give a side-by-side comparative overview of clinical trial regulatory commonalities and […]
December 21, 2019
Compared with generic drugs, the development of innovative chemical drugs is more difficult, expensive, and […]
December 21, 2019
In recent years, the CRO (Contract Research Organization) industry in China has entered a “golden […]